PATENT CLAIM ANALYSIS

Application Number: 15922376
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "064000"]

Abstract:
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

Claim (Index 50):
The compound of  claim 43 , wherein the compound is selected from the group represented by the following structures: or a pharmaceutically acceptable salt, polymorph, solvate, prodrug, N-oxide, or stereoisomer thereof, wherein the compound is present in a closed, cyclic form according to Formula I and as shown in the structures above, in a open, acyclic form according to Formula Ia, or mixtures thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.57692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14773717', '14759853', '15194433', '15675262', '14693318']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8233448631139907
- 35 USC 102 Novelty (BERT): 0.6026365519092723
- Combined Prediction Score: 0.8012740319935189
- Mean Citation Score: 509.04280400000016
- Max Citation Score: 553.43524
- Similarity Product: 443.8461152656936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test